Davis Aaron I. - Nov 17, 2021 Form 4 Insider Report for Odonate Therapeutics, Inc. (ODT)

Signature
/s/ Aaron I. Davis
Stock symbol
ODT
Transactions as of
Nov 17, 2021
Transactions value $
-$2,499,948
Form type
4
Date filed
11/19/2021, 06:22 PM
Previous filing
Jun 21, 2021
Next filing
Jan 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ODT Common Stock Sale -$380K -170K -26.33% $2.23* 476K Nov 17, 2021 Direct F1, F3
transaction ODT Common Stock Sale -$1.3M -600K -10.7% $2.17* 5.01M Nov 17, 2021 See footnote F2, F4
transaction ODT Common Stock Sale -$487K -250K -4.99% $1.95* 4.76M Nov 18, 2021 See footnote F2
transaction ODT Common Stock Sale -$57.5K -30K -6.31% $1.92* 446K Nov 19, 2021 Direct F1, F5
transaction ODT Common Stock Sale -$276K -150K -3.15% $1.84* 4.61M Nov 19, 2021 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are owned directly by the reporting person. The reporting person may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC ("Boxer Capital"), (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) the reporting person, and (iv) Joe Lewis (collectively, the "Boxer Group") Each member of the Boxer Group other than the reporting person disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
F2 These securities are owned directly by Boxer Capital and indirectly by the reporting person, Boxer Asset Management Inc. ("Boxer Management") and Joseph C. Lewis, by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
F3 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $1.97 to $2.95.
F4 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $2.0026 to $2.4018.
F5 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $1.84 to $1.96.